Rationale and design of the OPTIMIZE trial: OPen label multicenter randomized trial comparing standard IMmunosuppression with tacrolimus and mycophenolate mofetil with a low exposure tacrolimus regimen In combination with everolimus in de novo renal transplantation in Elderly patients

BACKGROUND: In 2019, more than 30 % of all newly transplanted kidney transplant recipients in The Netherlands were above 65 years of age. Elderly patients are less prone to rejection, and death censored graft loss is less frequent compared to younger recipients. Elderly recipients do have increased...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMC Nephrol
Autors principals: de Boer, S. E., Sanders, J. S.F., Bemelman, F. J., Betjes, M. G.H., Burgerhof, J. G.M., Hilbrands, L., Kuypers, D., van Munster, B. C., Nurmohamed, S. A., de Vries, A. P.J., van Zuilen, A. D., Hesselink, D. A., Berger, S. P.
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2021
Matèries:
Study Protocol
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8172178/
https://ncbi.nlm.nih.gov/pubmed/34078323
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12882-021-02409-8
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars